SSG
WST icon

Summit Securities Group’s West Pharmaceutical WST Stock Holding History

Summit Securities Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.01K Sell
12
-95
-89% -$23.6K ﹤0.01% 888
2025
Q4 		$29.4K Sell
107
-17
-14% -$4.65K 0.01% 730
2025
Q3 		$32.5K Sell
124
-1,066
-90% -$259K 0.01% 662
2025
Q2 		$260K Buy
+1,190
New +$254K 0.09% 206
2023
Q3 		– Sell
-96
Closed -$37K – 1098
2023
Q2 		$37K Sell
96
-49
-34% -$17.5K 0.02% 479
2023
Q1 		$50K Buy
145
+70
+93% +$20.5K 0.01% 429
2022
Q4 		$18K Buy
75
+58
+341% +$13.7K ﹤0.01% 927
2022
Q3 		$4K Sell
17
-138
-89% -$42K ﹤0.01% 841
2022
Q2 		$47K Buy
155
+124
+400% +$40.3K 0.02% 564
2022
Q1 		$13K Buy
+31
New +$12.1K ﹤0.01% 798

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return